Active	Status	Sponsor type	Region	Phase	Filter
8 Active 5 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Scherr, Johannes
NCT04983420: Effects of Different Polyphenol-containing Beverages on the Immune System and on Muscular Growth Factors	Completed	N/A	20	Europe	non-alcoholic Pilsner, non-alcoholic wheat beer, apple spritzer, lemonade	Balgrist University Hospital	Food Sensitivity	09/21	05/23
NCT05314985: Prehab Intervention in Patients Awaiting Total Knee Arthroplasty (TKA)	Completed	N/A	20	Europe	Prehab intervention	Balgrist University Hospital, Maastricht University	Osteoarthritis, Knee	09/22	04/23
NCT05594888: GRIP: Maximum Isometric Grip Strength Assessed With Three Different Hand-held Dynamometers	Recruiting	N/A	520	Europe		Johannes Scherr	Grip	09/24	12/24
NCT06813859: Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device	Not yet recruiting	N/A	20	NA	exercise testing	Balgrist University Hospital, University Hospital, Zürich	Fetal Distress	10/26	02/27
Spinner, Christoph D
EAGLE-1, NCT04010539 / 2018-001780-23: A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea	Completed	3	628	Europe, US, RoW	Gepotidacin, Ceftriaxone, Azithromycin	GlaxoSmithKline, BARDA	Gonorrhea	10/23	10/23
NCT03696160 / 2018-003481-13: The Late Presenter Treatment Optimisation Study	Completed	3	447	Europe	Biktarvy, Symtuza	NEAT ID Foundation, Gilead Sciences, Janssen Pharmaceuticals	HIV/AIDS	06/24	06/24
HIV CoCo, NCT05481216: HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV	Completed	N/A	2598	Europe	COVID-19, HIV-1 infection	NEAT ID Foundation, Gilead Sciences	HIV-1-infection, COVID-19	03/23	08/23
JUNGLE, NCT03518060: Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1	Completed	N/A	209	Europe	JULUCA	ViiV Healthcare, MUC Research GmbH	HIV Infections	05/23	05/23
Iakobouv, Roman
No trials found
Duvinage, Andre
No trials found